GSK_Annual_Report_2021

Inside the report GSK at a glance 1 Message from the Chairperson 2 Message from the Managing Director 3 Our COVID-19 response: Accelerating access. Delivering hope. 4 Our Covid heroes 6 Our key brands 7 Innovation 8 Performance 12 Trust 16 Financial highlights 20 Performance summary 21 Company Overview 1 Notice 23 Directors’ Report 35 Annexure ‘A’ to ‘G’ to Directors’ Report 46 Statutory Reports 23 Independent Auditors’ Report 85 Financial Statements 94 Form AOC-1 149 Biddle Sawyer Limited 150 Consolidated Financial Statements 164 Financial Statements 85 The ongoing COVID-19 crisis has thrown up several challenges for businesses globally. For the pharmaceutical sector, these challenges turned out to be volatile and with unprecedented levels of disruption. Companies went the extra mile to ensure that manufacturing and distribution of medicines continued uninterrupted, despite an uncertain and unpredictable operating environment. Rising to the occasion, we swiftly devised an agile roadmap and a response framework that enabled us to deliver on our purpose even through the most challenging phases of the crisis. We stood as committed as ever to ensure that patients’ access to healthcare not only remained continuous and sustained, but was accelerated further, lending us an opportunity to provide hope to them as they continue to trust us during their most difficult times. Accelerating Access. Delivering Hope.